Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GRAM Adds Board Member | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

GRAM Adds Board Member

Kontny brings thirty years of pharmaceutical experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Mark Kontny has joined Grand River Aseptic Manufacturing as a board member. Mark has 30 years of pharmaceutical experience, most recently serving as president, Pharmaceutical Development Services & Chief Scientific Officer for Patheon.
 
Previously, he served as divisional vice president for Abbott Laboratories, responsible for divisional staffs in IL, MA, Germany and Singapore. Earlier in his career, he spent close to ten years at Boehringer Ingelheim working with the pre-formulation, formulation and manufacturing of different dosage forms. He then become senior director at Pfizer and helped develop small molecules and biologics in both solid-dose and parenteral (injectable) forms.
 
Tom Ross, GRAM president and chief executive officer, said, “We look forward to the leadership that Mark will provide as a GRAM Board Member. His deep industry experience and knowledge of the pharmaceutical industry, specifically the parenteral space, will contribute to great decisions for the future. We have already benefitted from Mark’s counsel and we are happy to welcome him to the board.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters